Table 1.

Clinical and Biochemistry characteristics of Patients

Characteristic	Coronary Stenosis				P
	< 25%, N = 60	25–50%, N = 47	50–75%, N = 78	>75%, N =368
Age, yrs	56 ± 10	61 ± 9	59 ± 10	60 ± 11	0.055
Female	35 (58.3%)	11 (23.4%)	15 (19.2%)	94(25.6%)	< 0.001
BMI, kg/m2	25.7 ± 5.1	25.3 ± 2.6	26.8 ± 6.4	25.4 ± 5.2	0.302
Smoking	19 (31.7%)	25 (52.1%)	48(61.5%)	198 (53.8%)	0.02
Diabetes	13 (21.7%)	15 (31.3%)	28 (35.9%)	123 (33.4%)	0.224
hypertension	31 (51.7%)	28(58.3%)	46(60.0%)	255 (69.3%)	0.021
Prior MI/CI	3 (5.0%)	6 (12.5%)	11 (14.1%)	56 (15.2%)	0.183
Total cholesterol, mmol/L	3.997 ± 0.894	3.859 ± 0.945	3.971 ± 0.946	3.960 ± 1.056	0.890
HDL-C, mmol/L	1.157 ± 0.250	1.120 ± 0.285	1.045 ± 0.206	1.037 ± 0.261	0.004
LDL-C, mmol/L	2.281 ± 0.682	2.139 ± 0.724	2.401 ± 0.788	2.328 ± 0.800	0.286
HbA1c%	6.027 ± 1.071	6.320 ± 0.914	6.394 ± 1.099	6.598 ± 1.176	0.002
Cer (d18:1/16:0), μmol/L	0.226 ± 0.086	0.202 ± 0.075	0.217 ± 0.673	0.223 ± 0.085	0.371
Cer (d18:1/18:0), μmol/L	0.070 ± 0.043	0.057 ± 0.022	0.068 ± 0.030	0.068 ± 0.035	0.280
Cer (d18:1/24:1), μmol/L	2.463 ± 1.007	2.587 ± 0.996	2.620 ± 0.996	2.551 ± 0.993	0.756
Cer (d18:1/24:0), μmol/L	0.746 ± 0.395	0.694 ± 0.241	0.776 ± 0.294	0.782 ± 0.336	0.294
Cer (d18:1/16:0)/Cer (18:1/24:0)	0.096 ± 0.031	0.083 ± 0.026	0.088 ± 0.025	0.092 ± 0.030	0.049
Cer (d18:1/18:0)/Cer (18:1/24:0)	0.029 ± 0.015	0.024 ± 0.011	0.028 ± 0.013	0.028 ± 0.012	0.114
Cer (d18:1/24:1)/Cer (18:1/24:0)	0.322 ± 0.161	0.290 ± 0.130	0.318 ± 0.135	0.329 ± 0.148	0.108
hsCRP, mg/L	0.9(1.37)	0.95(1.507)	1.0(2.085)	1.05(2.32)	0.095
eGFR, mL/min/1.73m2	99.438 ± 14.123	97.974 ± 10.433	94.436 ± 17.180	92.792 ± 18.086	0.003
GRACE score	108.330 ± 23.281	105.945 ± 17.739	105.932 ± 22.645	105.736 ± 26.822	0.381
current medications (statins)	54(90.0%)	46(97.9%)	75(96.2%)	361(98.1%)	0.009

The clinical characteristics in coronary artery stenosis patients. (data is presented as mean ± SD, median and IQR or percentage)